Saturday, October 31, 2026

Semler Scientific And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Semler Scientific  And 4 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Semler Scientific (SMLR), Simpson Manufacturing Company (SSD), Caesarstone Ltd. (CSTE) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Semler Scientific (SMLR)

36% sales growth and 76.81% return on equity

Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States.

Semler Scientific's sales growth this year is anticipated to be 49.1% and 23.6% for next year.

Year-on-year quarterly revenue growth grew by 124.6%, now sitting on 50.29M for the twelve trailing months.

Volume

Today's last reported volume for Semler Scientific is 17997 which is 87.04% above its average volume of 9622.

Semler Scientific's sales growth is a negative 0% for the current quarter and 36% for the next. The company's growth estimates for the ongoing quarter and the next is 346.2% and 3.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 76.81%.

Volatility

Semler Scientific's last day, last week, and last month's current volatility was 0.45%, 1.18%, and 2.41%, respectively.

Semler Scientific's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.58% (day), 3.55% (last week), and 3.81% (last month), respectively.

Semler Scientific's Stock Yearly Top and Bottom Value

Semler Scientific's stock is valued at $115.00 at 16:22 EST, way below its 52-week high of $129.00 and way higher than its 52-week low of $48.15.

Semler Scientific's Moving Average

Semler Scientific's value is below its 50-day moving average of $116.81 and higher than its 200-day moving average of $108.46.

2. Simpson Manufacturing Company (SSD)

31.6% sales growth and 22.17% return on equity

Simpson Manufacturing Co., Inc., through its subsidiaries, designs, engineers, manufactures, and sells wood and concrete building construction products.

Simpson Manufacturing Company's sales growth this year is expected to be 17.7% and 9.4% for next year.

Year-on-year quarterly revenue growth grew by 25.8%, now sitting on 1.42B for the twelve trailing months.

Volume

Today's last reported volume for Simpson Manufacturing Company is 93644 which is 38.32% below its average volume of 151831.

Simpson Manufacturing Company's sales growth for the next quarter is 31.6%. The company's growth estimates for the ongoing quarter and the next is 31.1% and 12.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 22.17%.

Volatility

Simpson Manufacturing Company's last day, last week, and last month's current volatility was 0.96%, 1.08%, and 1.13%, respectively.

Simpson Manufacturing Company's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.67% (day), 2.11% (last week), and 2.04% (last month), respectively.

Simpson Manufacturing Company's Stock Yearly Top and Bottom Value

Simpson Manufacturing Company's stock is valued at $112.78 at 16:22 EST, under its 52-week high of $119.77 and way above its 52-week low of $86.20.

Simpson Manufacturing Company's Moving Average

Simpson Manufacturing Company's value is higher than its 50-day moving average of $110.61 and above its 200-day moving average of $106.87.

3. Caesarstone Ltd. (CSTE)

27% sales growth and 3.81% return on equity

Caesarstone Ltd., together with its subsidiaries, develops, manufactures, and markets engineered quartz surfaces under the Caesarstone brand in the United States, Australia, Canada, Latin America, Asia, Israel, Europe, the Middle East, and Africa.

Caesarstone Ltd.'s sales growth this year is anticipated to be 24.8% and 6.1% for next year.

Year-on-year quarterly revenue growth grew by 15.4%, now sitting on 505.89M for the twelve trailing months.

Volume

Today's last reported volume for Caesarstone Ltd. is 151328 which is 12% above its average volume of 135104.

Caesarstone Ltd.'s sales growth for the next quarter is 27%. The company's growth estimates for the present quarter and the next is a negative 50% and 30.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 3.81%.

Volatility

Caesarstone Ltd.'s last day, last week, and last month's current volatility was 2.83%, 2.36%, and 1.75%, respectively.

Caesarstone Ltd.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 9.77% (day), 4.91% (last week), and 3.33% (last month), respectively.

Caesarstone Ltd.'s Stock Yearly Top and Bottom Value

Caesarstone Ltd.'s stock is valued at $13.78 at 16:22 EST, way under its 52-week high of $19.80 and way higher than its 52-week low of $9.23.

Caesarstone Ltd.'s Moving Average

Caesarstone Ltd.'s worth is below its 50-day moving average of $14.01 and under its 200-day moving average of $14.17.

4. Arista Networks (ANET)

15.2% sales growth and 21.64% return on equity

Arista Networks, Inc. develops, markets, and sells cloud networking solutions in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific.

Arista Networks's sales growth this year is expected to be 19.2% and 11.7% for next year.

Year-on-year quarterly revenue growth grew by 30.8%, now sitting on 2.63B for the twelve trailing months.

Volume

Today's last reported volume for Arista Networks is 314845 which is 26.61% below its average volume of 429026.

Arista Networks's sales growth for the next quarter is 15.2%. The company's growth estimates for the ongoing quarter and the next is 20.4% and 7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.64%.

Volatility

Arista Networks's last day, last week, and last month's current volatility was 0.40%, 0.54%, and 0.90%, respectively.

Arista Networks's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.14% (day), 2.83% (last week), and 1.97% (last month), respectively.

Arista Networks's Stock Yearly Top and Bottom Value

Arista Networks's stock is valued at $377.60 at 16:22 EST, under its 52-week high of $384.00 and way above its 52-week low of $192.96.

Arista Networks's Moving Average

Arista Networks's worth is higher than its 50-day moving average of $370.31 and way above its 200-day moving average of $327.71.

5. Bank OZK (OZK)

6.2% sales growth and 12.27% return on equity

Bank OZK provides various retail and commercial banking services.

Bank OZK's sales growth this year is anticipated to be 5.1% and 1.6% for next year.

Year-on-year quarterly revenue growth grew by 80.2%, now sitting on 1.1B for the twelve trailing months.

Volume

Today's last reported volume for Bank OZK is 488948 which is 18.37% below its average volume of 598998.

Bank OZK's sales growth for the next quarter is 6.2%. The company's growth estimates for the present quarter and the next is 135.9% and 4.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.27%.

Volatility

Bank OZK's last day, last week, and last month's current volatility was 3.70%, 1.87%, and 1.99%, respectively.

Bank OZK's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.01% (day), 3.22% (last week), and 3.18% (last month), respectively.

Bank OZK's Stock Yearly Top and Bottom Value

Bank OZK's stock is valued at $43.16 at 16:22 EST, under its 52-week high of $45.83 and way higher than its 52-week low of $20.10.

Bank OZK's Moving Average

Bank OZK's worth is above its 50-day moving average of $41.14 and above its 200-day moving average of $41.10.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com